{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Acacia catechu", "antiviral agent", "bioactive peptide", "dengue virus", "peptide inhibitor"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33172110", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "03", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "06"}], "Language": ["eng"], "ELocationID": ["1267", "10.3390/v12111267"], "Journal": {"ISSN": "1999-4915", "JournalIssue": {"Volume": "12", "Issue": "11", "PubDate": {"Year": "2020", "Month": "Nov", "Day": "06"}}, "Title": "Viruses", "ISOAbbreviation": "Viruses"}, "ArticleTitle": "A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant <i>Acacia catechu</i> Binds to Dengue Virus and Inhibits Cell Entry.", "Abstract": {"AbstractText": ["Dengue virus (DENV) infection has become a critically important globally prevalent infectious disease, especially in tropical and subtropical countries. Since neither currently exists, there is an urgent need for an effective vaccine to prevent, and a specific drug to treat DENV infection. Therapeutic peptides represent an attractive alternative for development into anti-DENV drugs due to their safety and their diverse biological and chemical properties. We recently reported novel bioactive peptides extracted from the Asian medicinal plant <i>Acacia catechu</i> that efficiently inhibited all four DENV serotypes. In this study, we investigated the anti-DENV activity of a synthetic bioactive peptide derived from this plant. The most effective peptide (designated Pep-RTYM) inhibited DENV infection with a half-maximal inhibition concentration value of 7.9 \u03bcM. Time-of-addition study demonstrated that Pep-RTYM interacted with DENV particles and inhibited cellular entry. Pep-RTYM at 50 \u03bcM significantly reduced DENV production in Vero-kidney epithelial cells about 1000-fold, but it could decrease the virus production in Huh7 hepatocyte cells approximately 40-fold. Binding of Pep-RTYM to DENV particles may prevent virus interaction with cellular receptor and subsequent virus entry. This finding suggests a potential role of Pep-RTYM in the development of a novel anti-DENV drug."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand."}, {"Identifier": [], "Affiliation": "Research Center in Bioresources for Agriculture, Industry and Medicine, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand."}], "LastName": "Panya", "ForeName": "Aussara", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand."}], "LastName": "Sawasdee", "ForeName": "Nunghathai", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand."}], "LastName": "Songprakhon", "ForeName": "Pucharee", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand."}, {"Identifier": [], "Affiliation": "Research Center in Bioresources for Agriculture, Industry and Medicine, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand."}], "LastName": "Tragoolpua", "ForeName": "Yingmanee", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand."}, {"Identifier": [], "Affiliation": "Research Center in Bioresources for Agriculture, Industry and Medicine, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand."}], "LastName": "Rotarayanont", "ForeName": "Siriphorn", "Initials": "S"}, {"Identifier": ["0000-0002-2421-7859"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand."}], "LastName": "Choowongkomon", "ForeName": "Kiattawee", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand."}], "LastName": "Yenchitsomanus", "ForeName": "Pa-Thai", "Initials": "PT"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Viruses", "NlmUniqueID": "101509722", "ISSNLinking": "1999-4915"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Acacia"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": ["drug effects"], "DescriptorName": "Dengue Virus"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Peptides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Internalization"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}], "CoiStatement": "All authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Back A.T., Lundkvist A. Dengue viruses\u2014An overview. Infect. Ecol. Epidemiol. 2013;3:19839.", "ArticleIdList": ["PMC3759171", "24003364"]}, {"Citation": "WHO Neglected Tropical Diseases.  [(accessed on 5 November 2020)]; Available online:  http://origin.searo.who.int/entity/vector_borne_tropical_diseases/data/data_factsheet/en/."}, {"Citation": "Bos S., Gadea G., Despres P. Dengue: A growing threat requiring vaccine development for disease prevention. Pathog. Glob. Health. 2018;112:294\u2013305. doi: 10.1080/20477724.2018.1514136.", "ArticleIdList": ["10.1080/20477724.2018.1514136", "PMC6381545", "30213255"]}, {"Citation": "Thomas S.J., Yoon I.K. A review of Dengvaxia\u00ae: Development to deployment. Hum. Vaccines Immunother. 2019;15:2295\u20132314. doi: 10.1080/21645515.2019.1658503.", "ArticleIdList": ["10.1080/21645515.2019.1658503", "PMC6816420", "31589551"]}, {"Citation": "Sabchareon A., Wallace D., Sirivichayakul C., Limkittikul K., Chanthavanich P., Suvannadabba S., Jiwariyavej V., Dulyachai W., Pengsaa K., Wartel T.A., et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial. Lancet. 2012;380:1559\u20131567. doi: 10.1016/S0140-6736(12)61428-7.", "ArticleIdList": ["10.1016/S0140-6736(12)61428-7", "22975340"]}, {"Citation": "Liu Y., Liu J., Cheng G. Vaccines and immunization strategies for dengue prevention. Emerg. Microbes Infect. 2016;5:e77. doi: 10.1038/emi.2016.74.", "ArticleIdList": ["10.1038/emi.2016.74", "PMC5141265", "27436365"]}, {"Citation": "Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitaya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., et al. Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity. J. Infect. Dis. 2000;181:2\u20139. doi: 10.1086/315215.", "ArticleIdList": ["10.1086/315215", "10608744"]}, {"Citation": "Ben-Shachar R., Schmidler S., Koelle K. Drivers of Inter-individual Variation in Dengue Viral Load Dynamics. PLoS Comput. Biol. 2016;12:e1005194. doi: 10.1371/journal.pcbi.1005194.", "ArticleIdList": ["10.1371/journal.pcbi.1005194", "PMC5113863", "27855153"]}, {"Citation": "De La Guardia C., Lleonart R. Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors. BioMed Res. Int. 2014;2014:13. doi: 10.1155/2014/825039.", "ArticleIdList": ["10.1155/2014/825039", "PMC4135166", "25157370"]}, {"Citation": "Norazharuddin H., Lai N.S. Roles and Prospects of Dengue Virus Non-structural Proteins as Antiviral Targets: An Easy Digest. Malays. J. Med. Sci. 2018;25:6\u201315. doi: 10.21315/mjms2018.25.5.2.", "ArticleIdList": ["10.21315/mjms2018.25.5.2", "PMC6419879", "30914859"]}, {"Citation": "Krishnan M.N., Garcia-Blanco M.A. Targeting host factors to treat West Nile and dengue viral infections. Viruses. 2014;6:683\u2013708. doi: 10.3390/v6020683.", "ArticleIdList": ["10.3390/v6020683", "PMC3939478", "24517970"]}, {"Citation": "Panya A., Bangphoomi K., Choowongkomon K., Yenchitsomanus P.-T. Peptide Inhibitors against Dengue Virus Infection. Chem. Biol. Drug Des. 2014;84:148\u2013157. doi: 10.1111/cbdd.12309.", "ArticleIdList": ["10.1111/cbdd.12309", "24612829"]}, {"Citation": "Panya A., Sawasdee N., Junking M., Srisawat C., Choowongkomon K., Yenchitsomanus P.T. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Chem. Biol. Drug Des. 2015;86:1093\u20131104. doi: 10.1111/cbdd.12576.", "ArticleIdList": ["10.1111/cbdd.12576", "25891143"]}, {"Citation": "Panya A., Yongpitakwattana P., Budchart P., Sawasdee N., Krobthong S., Paemanee A., Roytrakul S., Rattanabunyong S., Choowongkomon K., Yenchitsomanus P.-T. Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu. Chem. Biol. Drug Des. 2019;93:100\u2013109. doi: 10.1111/cbdd.13400.", "ArticleIdList": ["10.1111/cbdd.13400", "30225997"]}, {"Citation": "Phumesin P., Junking M., Panya A., Yongpitakwattana P., Noisakran S., Limjindaporn T., Yenchitsomanus P.-T. Vivo-morpholino oligomers strongly inhibit dengue virus replication and production. Arch. Virol. 2018;163:867\u2013876. doi: 10.1007/s00705-017-3666-9.", "ArticleIdList": ["10.1007/s00705-017-3666-9", "29260328"]}, {"Citation": "Phumesin P., Junking M., Panya A., Yongpitakwattana P., Noisakran S., Limjindaporn T., Yenchitsomanus P.-T. Inhibition of dengue virus replication in monocyte-derived dendritic cells by vivo-morpholino oligomers. Virus Res. 2019;260:123\u2013128. doi: 10.1016/j.virusres.2018.11.014.", "ArticleIdList": ["10.1016/j.virusres.2018.11.014", "30503719"]}, {"Citation": "Rattanaburee T., Junking M., Panya A., Sawasdee N., Songprakhon P., Suttitheptumrong A., Limjindaporn T., Haegeman G., Yenchitsomanus P.-T. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A. Antivir. Res. 2015;124:83\u201392. doi: 10.1016/j.antiviral.2015.10.005.", "ArticleIdList": ["10.1016/j.antiviral.2015.10.005", "26542647"]}, {"Citation": "Sreelatha L., Malakar S., Songprakhon P., Morchang A., Srisawat C., Noisakran S., Yenchitosomanus P.T., Limjindaporn T. Serine protease inhibitor AEBSF reduces dengue virus infection via decreased cholesterol synthesis. Virus Res. 2019;271:197672. doi: 10.1016/j.virusres.2019.197672.", "ArticleIdList": ["10.1016/j.virusres.2019.197672", "31386864"]}, {"Citation": "Sreekanth G.P., Panaampon J., Suttitheptumrong A., Chuncharunee A., Bootkunha J., Yenchitsomanus P.T., Limjindaporn T. Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection. Antivir. Res. 2019;166:42\u201355. doi: 10.1016/j.antiviral.2019.03.011.", "ArticleIdList": ["10.1016/j.antiviral.2019.03.011", "30928439"]}, {"Citation": "Syst\u00e8mes D. Biovia, Discovery Studio Modeling Environment. Dassault Syst\u00e8mes Biovia; San Diego, CA, USA: 2016."}, {"Citation": "Jones G., Willett P., Glen R.C., Leach A.R., Taylor R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997;267:727\u2013748. doi: 10.1006/jmbi.1996.0897.", "ArticleIdList": ["10.1006/jmbi.1996.0897", "9126849"]}, {"Citation": "Modis Y., Ogata S., E Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA. 2003;100:6986\u20136991. doi: 10.1073/pnas.0832193100.", "ArticleIdList": ["10.1073/pnas.0832193100", "PMC165817", "12759475"]}, {"Citation": "Sukupolvi-Petty S., Austin S.K., Purtha W.E., Oliphant T., Nybakken G.E., Schlesinger J.J., Roehrig J.T., Gromowski G.D., Barrett A.D., Fremont D.H., et al. Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes. J. Virol. 2007;81:12816\u201312826. doi: 10.1128/JVI.00432-07.", "ArticleIdList": ["10.1128/JVI.00432-07", "PMC2169112", "17881453"]}, {"Citation": "Samanta J. Dengue and its effects on liver. World J. Clin. Cases. 2015;3:125\u2013131. doi: 10.12998/wjcc.v3.i2.125.", "ArticleIdList": ["10.12998/wjcc.v3.i2.125", "PMC4317605", "25685758"]}, {"Citation": "Lau J.L., Dunn M.K. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic Med. Chem. 2018;26:2700\u20132707. doi: 10.1016/j.bmc.2017.06.052.", "ArticleIdList": ["10.1016/j.bmc.2017.06.052", "28720325"]}, {"Citation": "Cruz-Oliveira C., Freire J.M., Concei\u00e7\u00e3o T.M., Higa L.M., Castanho M.A., Da Poian A.T. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 2015;39:155\u2013170. doi: 10.1093/femsre/fuu004.", "ArticleIdList": ["10.1093/femsre/fuu004", "25725010"]}, {"Citation": "Talarico L.B., A Pujol C., Zibetti R.G.M., Far\u00eda P.C.S., Noseda M.D., Duarte M.E.R., Damonte E.B. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antivir. Res. 2005;66:103\u2013110. doi: 10.1016/j.antiviral.2005.02.001.", "ArticleIdList": ["10.1016/j.antiviral.2005.02.001", "15911027"]}, {"Citation": "Lee E., Pavy M., Young N., Freeman C., Lobigs M. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antivir. Res. 2006;69:31\u201338. doi: 10.1016/j.antiviral.2005.08.006.", "ArticleIdList": ["10.1016/j.antiviral.2005.08.006", "16309754"]}, {"Citation": "Ono L., Wollinger W., Rocco I.M., Coimbra T.L., Gorin P.A., Sierakowski M.-R. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain) Antivir. Res. 2003;60:201\u2013208. doi: 10.1016/S0166-3542(03)00175-X.", "ArticleIdList": ["10.1016/S0166-3542(03)00175-X", "14638396"]}, {"Citation": "Alhoot M.A., Rathinam A.K., Wang S.M., Manikam R., Sekaran S.D. Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral Peptides. Int. J. Med. Sci. 2013;10:719\u2013729. doi: 10.7150/ijms.5037.", "ArticleIdList": ["10.7150/ijms.5037", "PMC3638295", "23630436"]}, {"Citation": "Bruno B.J., Miller G.D., Lim C.S. Basics and recent advances in peptide and protein drug delivery. Ther. Deliv. 2013;4:1443\u20131467. doi: 10.4155/tde.13.104.", "ArticleIdList": ["10.4155/tde.13.104", "PMC3956587", "24228993"]}, {"Citation": "De Marco R., Cerisoli L. Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization. Curr. Pharm. Des. 2010;16:3185\u20133203. doi: 10.2174/138161210793292555.", "ArticleIdList": ["10.2174/138161210793292555", "20687878"]}, {"Citation": "Nguyen L.T., Chau J.K., Perry N.A., De Boer L., Zaat S.A.J., Vogel H.J. Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs. PLoS ONE. 2010;5:e12684. doi: 10.1371/journal.pone.0012684.", "ArticleIdList": ["10.1371/journal.pone.0012684", "PMC2937036", "20844765"]}, {"Citation": "Carmona G., Rodr\u00edguez A., Ju\u00e1rez D., Corzo G., Villegas E. Improved Protease Stability of the Antimicrobial Peptide Pin2 Substituted with d-Amino Acids. Protein J. 2013;32:456\u2013466. doi: 10.1007/s10930-013-9505-2.", "ArticleIdList": ["10.1007/s10930-013-9505-2", "23925670"]}, {"Citation": "Knappe D., Henklein P., Hoffmann R., Hilpert K. Easy Strategy to Protect Antimicrobial Peptides from Fast Degradation in Serum. Antimicrob. Agents Chemother. 2010;54:4003\u20134005. doi: 10.1128/AAC.00300-10.", "ArticleIdList": ["10.1128/AAC.00300-10", "PMC2934954", "20585128"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "7"}, {"Year": "2020", "Month": "11", "Day": "3"}, {"Year": "2020", "Month": "11", "Day": "4"}, {"Year": "2020", "Month": "11", "Day": "11", "Hour": "1", "Minute": "2"}, {"Year": "2020", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33172110", "PMC7694746", "10.3390/v12111267", "v12111267"]}}], "PubmedBookArticle": []}